GlassScriptPrepare for your visit
Sanjay Mishra
Child & Adolescent Psychiatry · Carmel, IN · NPI 1144204751
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$3,137.61
in general payments reported to CMS, 2019-2025 · $118 in 2025
The $118 reported for 2025 was less than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Who reported paying
General payments only, top 6 by amount.
- Supernus Pharmaceuticals, INC. $871.19
- Abbvie INC. $637.59
- Corium, LLC $366.84
- Sunovion Pharmaceuticals INC. $335.44
- Takeda Pharmaceuticals U.S.A., INC. $252.90
- Axsome Therapeutics, INC. $152.36
Drugs and devices associated with these payments
Vraylar Qelbree Azstarys Auvelity Trintellix Quviviq Adzenys Xr-Odt Jornay Pm Caplyta Aplenzin Wellbutrin
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Sanjay Mishra listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/97386/sanjay-mishra